Blood donor rejection rate: HemoCue hemoglobin analyzer vs. microhematocrit

Area of Science:

• Blood banking and transfusion medicine
• Clinical pathology and laboratory diagnostics
• Hematology and analytical methods

Background:

• Historically, various methods have been used for hemoglobin and hematocrit determination, with copper sulfate screening being common.
• The HemoCue hemoglobin analyzer represents newer technology for analyzing capillary blood specimens.
• The microhematocrit method has been a standard for hematocrit measurement and as a follow-up test.

Purpose of the Study:

• To compare the HemoCue hemoglobin assay with the microhematocrit method.
• To evaluate potential differences in results that could influence blood donor eligibility.
• To assess the suitability of these methods for blood donor screening.

Main Methods:

• Comparison of hemoglobin values obtained using the HemoCue instrument.
• Comparison of hematocrit values obtained using the microhematocrit method.
• Analysis of blood samples from prospective donors.

Main Results:

• The study aimed to identify significant differences between the two methodologies.
• The potential impact of these differences on donor rejection rates was investigated.
• The comparability of HemoCue hemoglobin and microhematocrit methods for donor screening was assessed.

Conclusions:

• The study sought to determine if HemoCue hemoglobin testing and microhematocrit analysis yield comparable results for blood donor screening.
• Findings are intended to inform decisions regarding the adoption of new or existing methodologies in blood donation centers.
• The research addresses the critical need for accurate and reliable screening methods to ensure blood supply safety.